Press Release MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome 6 November 2025
Press Release Eilean Therapeutics to Present First-in-Class, Wild-Type-Sparing JAK2-JH2/V617F Inhibitor ZE74-0282 at ASH 2025 and Initiate Clinical Studies in December 2025 6 November 2025
Press Release ATDev Joins $41 Million ARPA-H Initiative to Build the Future of Robotic Mobility and Independence 6 November 2025
Press Release STAGWELL INC. (NASDAQ: STGW) REPORTS RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 6 November 2025
Press Release ResumeBuilder.com Survey: 1 in 3 Dating App Users Are Swiping for Jobs, Not Love 6 November 2025
Press Release Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek® 2025 6 November 2025
Press Release REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights 6 November 2025
Press Release Tripadvisor, Inc. Earnings Press Release Available on Company’s Investor Relations Site 6 November 2025
Press Release Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc. 6 November 2025
